Astellas Pharma Canada Appoints New President
01-Jul-2010
- Canada
Astellas Pharma Canada, Inc. announced that Michael Tremblay has been appointed president of the Canadian subsidiary of Astellas Pharma Inc. His predecessor, Fumiaki Sakurai, will return to Japan to assume a new role in the company's Asia International Division.
Mr. Tremblay has almost 35 years of broad experience in the pharmaceutical industry, spanning areas of sales and marketing, business development, training and customer relationship management. Mr. Tremblay has been with Astellas for ten years, and since 2007, has acted as vice president of Sales and Marketing for the company. In his new role as president, Mr. Tremblay will lead the Canadian executive team while enhancing and growing Astellas' business presence in Canada.
Other news from the department people
